Literature DB >> 30595475

The strategy on managing cervical lymph nodes of patients with maxillary gingival squamous cell carcinoma.

Yi Qu1, Yanbin Liu1, Ming Su1, Yang Yang1, Zhengxue Han1, Lizheng Qin2.   

Abstract

PURPOSE: We aimed to determine the risk of occult cervical metastasis of maxillary gingival squamous cell carcinoma (SCC), the predisposing factors for occult cervical metastasis and the therapeutic value of elective neck dissection (END) in survival of clinically negative neck node (cN0) patients.
METHODS: A retrospective study of patients with maxillary gingival SCC was conducted in our hospital. Clinical information including age, gender, TNM staging, pathological staging, as well as other demographic and clinical data was acquired and analyzed. The Kaplan-Meier method was used to evaluate overall survival rate. Descriptive and bivariate statistics were computed.
RESULTS: The sample was composed of 107 patients (43 men, 64 women). The overall lymph node metastasis (LNM) rate was 28%. The LNM rates were 7.1%, 15%, 41.7% and 44.8% for T1 to T4 stage tumors, and were 9.3%, 46.8%, and 50% for pathological grades I to III. The tumor stage and pathological grade showed a significant relationship with cervical metastasis (P < 0.01). The 5-year survival rate was higher in those who had an END (76%) when compared to those who did not receive an END (46.4%; P < 0.05). With regard to the nodal status, pN0 group had a higher survival rate than pN + group (P < 0.01).
CONCLUSION: The results of this study suggest that the risk of LNM for SCC originating from the maxillary gingiva is higher than expected and comparable to that for other oral sites. We recommend END for T3 and T4 stage cN0 patients, especially for moderately and poorly-differentiated tumors.
Copyright © 2018 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cervical metastasis; Elective neck dissection; Maxillary gingiva; Squamous cell carcinoma

Mesh:

Year:  2018        PMID: 30595475     DOI: 10.1016/j.jcms.2018.12.008

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  2 in total

1.  Nomogram forecasting 3-, 5-, and 8-year overall survival and cancer-specific survival of gingival squamous cell carcinoma.

Authors:  Lei Yan; Weizhuo Deng; Lina Guan; Hao Xu
Journal:  Cancer Med       Date:  2020-09-22       Impact factor: 4.452

2.  Systematic review and meta-analysis of cervical metastases in oral maxillary squamous cell carcinoma.

Authors:  Clemente Chia; Seraphina Key; Zubair Hasan; Sohaib Virk; Faruque Riffat
Journal:  Cancer Rep (Hoboken)       Date:  2021-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.